Kathleen (Taffy) Kingscott

Kathleen Kingscott is Vice President, Strategic Partnerships for IBM Research.  She is responsible for developing collaborative research partnerships between IBM, industry, academia and government. Ms. Kingscott is a member of the National Academy of Sciences Innovation Policy Forum and is IBM’s alternate member of the Semiconductor Industry Association Board of Directors.  She chairs the CTO Work Group of the SIA. She is a member of the Board of Managers of the American Institute of Physics Publishing and is chair of the Compensation Committee for the AIPP Board.

Previously, Kathleen held the IBM Industry Chair at the Industrial College of the Armed Forces, National Defense University, as the first faculty member from industry at the college. Other earlier roles include Director, Worldwide Innovation Policy for IBM with responsibility for worldwide public policy matters regarding innovation, science and technology.  She has held other leadership roles in IBM, including Congressional relations, information technology marketing and marketing management positions. Kathleen formerly served as a member of the Executive Committee of the Electronics Division of the National Defense Industrial Association. She was a member of the Secretary of Commerce’s Manufacturing Council 2015-2016. She was a founder and served as a long-time co-chair of the Task Force on American Innovation, a major coalition of companies, university and trade associations, and professional societies that supports federal investment in scientific research.

Ms. Kingscott has been with IBM 40+ years.  She holds a B.A. from Vanderbilt University.

The United States Needs a National Standards Strategy

By Richard Taffet and Chris Borges Competition among nations for technological and economic leadership is intense, especially between the United States and the People’s Republic of China (PRC). The PRC has followed a decades-long, targeted strategy focused on leadership in critical and emerging technologies (CETs), and, according to some, it has
Read More

How Most-Favored Nation Policy Could Undermine U.S. Leadership

By Dr. Anne Pritchett The United States is the global leader in biopharmaceutical innovation. This leadership is built on the pillars of strong intellectual property protection, substantial investment in research and development (R&D), and a robust innovation ecosystem. These factors, combined with a market-based system that supports competitive drug pricing, encourage innovation and
Read More

U.S. Patenting Abroad — A Quiet Trade Advantage

By Chris Borges   Although patents are territorial, meaning they are limited to the jurisdiction in which they are granted, the networks spanning innovation and commerce are global. U.S. inventors routinely seek patent protection in markets abroad to safeguard their innovations, facilitate exports, and access new customers. By requiring member states
Read More